Sep 2026· World Journal of Advanced Research and Reviews· 0 citations
TL;DR
Serum vitamin D levels were markedly reduced in patients with renal failure compared with healthy individuals, irrespective of demographic or clinical factors, and highlight the importance of routine assessment and supplementation of vitamin D as part of the comprehensive management of renal failure in Sudanese patients.
Abstract
Background: Vitamin D deficiency is a frequent metabolic disturbance in patients with chronic kidney disease (CKD) and contributes to mineral-bone disorder, cardiovascular risk, and poor disease outcomes. This study aimed to evaluate serum 25-hydroxyvitamin D [25(OH)D] concentrations among patients with renal failure compared with healthy controls in Gezira State, Sudan.
Methods: A hospital-based cross-sectional case–control study was conducted at Gezira Hospital for Renal Diseases and Surgery, Wad Medani, Sudan, from December 2024 to October 2025. The study included 70 patients diagnosed with renal failure and 73 apparently healthy age- and sex-matched controls. Venous blood samples were collected and analyzed for serum 25(OH)D concentrations using a chemiluminescence immunoassay (CLIA) method. Data were analyzed using SPSS version 26.0, and comparisons between groups were performed using the independent-samples t-test and chi-square test, with a p-value < 0.05 considered statistically significant.
Results: The mean serum vitamin D level among renal failure patients was significantly lower (9.7 ± 5.9 ng/mL) compared to controls (23.0 ± 7.3 ng/mL, p < 0.001). Most patients were older than 50 years (52.9%) and predominantly male (55.7%). Vitamin D deficiency was observed across all demographic and clinical subgroups of renal failure patients, with no significant variation by age, gender, residence, marital status, education level, duration of renal failure, or comorbidities (p > 0.05 for all). Although those taking vitamin D supplements exhibited slightly higher mean levels (11.12 ± 7.59 ng/mL) than non-supplemented patients (9.61 ± 5.84 ng/mL), the difference was not statistically significant (p = 0.587).
Conclusion: Serum vitamin D levels were markedly reduced in patients with renal failure compared with healthy individuals, irrespective of demographic or clinical factors. These findings highlight the importance of routine assessment and supplementation of vitamin D as part of the comprehensive management of renal failure in Sudanese patients.
Background: Vitamin D plays a well-established role in bone metabolism, but recent evidence highlights its broader impact on cardiovascular health. Deficiency has been linked to hypertension, metabolic syndrome, diabetes mellitus, and atherosclerosis.
Aims and Objectives: This study aimed to assess serum 25-hydroxyvita...
Abhijit Saha, Arun Kumar, M. Das· Asian Journal of Medical Sci...· 0 citations
Purpose This study aimed to investigate the association between serum 25-hydroxyvitamin D (25[OH]D) levels and metabolic dysfunction-associated steatotic liver disease (MASLD) in older patients with type 2 diabetes mellitus. Patients and Methods This retrospective cross-sectional study included 1044 older patients with...
Background: Chronic kidney disease (CKD) is a progressive condition commonly associated with disturbances in vitamin D metabolism, secondary hyperparathyroidism, and renal anemia. This study aimed to assess serum vitamin D and parathyroid hormone (PTH) levels in patients with CKD-related anemia undergoing hemodialysis...
Samy H. Khwaiter· Israa University Journal for...· 0 citations
While ferritin and Vitamin D were associated with the presence of NAFLD, CRP correlated significantly with disease severity, suggesting its potential utility as a marker of disease progression and inflammatory burden.
M. Anton, B. Shanthi, V. Elumalai et al.· Journal of Clinical and Diag...· 0 citations
Dyslipidemia has been emerged as a major contributing factor to the close association between (CKD) and a higher chance of developing cardiovascular disease. A condition of lipid metabolism brought on by a combination of hereditary and environmental factors called dyslipidemia. This study examines how patients with ren...
R. M., Sarah Sarah· Research Journal of Pharmacy...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.